|
APGE Apogee Therapeutics Inc 1974640 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-74,111,000.00 |
| Balance Sheet |
|
Current Assets
|
$1,073,797,000.00 |
|
Assets
|
$1,293,654,000.00 |
|
Current Liabilities
|
$32,952,000.00 |
|
Liabilities
|
$37,861,000.00 |
|
Shares Out
|
74882396.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-55,570,000.00 |
|
Investing Cash Flow
|
$-35,349,000.00 |
| Market Analysis |
Market Cap
|
$10,056,705,782.80 |
|
Price
|
$134.09 |
|
PB
|
2.68 |
|
EPS
|
-1.06 |
|
FCF
|
$-60,717,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:18 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:12 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
|
|
|
2026-05-11 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APGE documents filed with the SEC.
APGE Filings
Clear
